Orchidopexy Randomized Clinical Assessment (ORCA)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02235623 |
Recruitment Status :
Recruiting
First Posted : September 10, 2014
Last Update Posted : May 12, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Unilateral Cryptorchidism | Procedure: Single-stage Fowler-Stephens orchidopexy (FSO) Procedure: Two-stage Fowler-Stephens orchidopexy (FSO) | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 66 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Randomized Trial of One Stage vs Two Stage Orchidopexy for Abdominal Undescended Testis |
Study Start Date : | August 2014 |
Estimated Primary Completion Date : | December 2022 |
Estimated Study Completion Date : | December 2023 |
Arm | Intervention/treatment |
---|---|
Stage 1- Single-stage Fowler-Stephens orchidopexy (FSO)
Stage 1 single surgery to clip the vessels to the testis, divide the spermatic vessels and bring the testis into the scrotum.
|
Procedure: Single-stage Fowler-Stephens orchidopexy (FSO) |
Stage 2- Two-stage Fowler-Stephens orchidopexy (FSO)
Stage 2 2 surgeries: 1st surgery-Clip vessels to testis. 2nd surgery done 6-12 months later, divide the spermatic vessels and bring the testis into the scrotum.
|
Procedure: Two-stage Fowler-Stephens orchidopexy (FSO) |
- To evaluate the volume of the operated testis via ultrasound measurements. [ Time Frame: 6-12 months after final FSO surgery ]To evaluate the volume of the operated testis at 6-12 months after single-stage Fowler-Stephens orchidopexy (FSO) (6-12 months after two- stage FSO), as determined by ultrasound measurements. This will be compared to the intra-operative testicular measurements done during the laparoscopy.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 4 Months to 36 Months (Child) |
Sexes Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Boys age 4 months to 36 months
- Undergoing diagnostic laparoscopy for unilateral non-palpable testis, who are found at laparoscopy to have an abdominal undescended testis, in whom a Fowler-Stephens Orchiopexy would be appropriate.
Exclusion Criteria:
- Age > 36 months
- Age < 4 months
- Bilateral cryptorchidism
- Solitary testis
- Findings at laparoscopy for which Fowler-Stephens Orchiopexy would not be indicated
- Intra-operative mobility of the intra-abdominal testis such that, with no (or minimal) mobilization, the testis is able to reach the contralateral internal ring, without dividing the spermatic vessels.
- Assessment of whether a single stage primary orchidopexy will be performed, is entirely at the discretion of the attending surgeon.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02235623
Contact: Rachel Saunders, BA | 617-355-4720 | Rachel.Saunders@childrens.harvard.edu |
United States, Massachusetts | |
Boston Children's Hospital | Recruiting |
Boston, Massachusetts, United States, 02115 | |
Contact: Rachel Saunders, BA 617-355-4720 Rachel.Saunders@childrens.harvard.edu | |
Principal Investigator: Caleb P Nelson, MD, MPH |
Principal Investigator: | Caleb P Nelson, MD, MPH | Boston Children's Hospital |
Responsible Party: | Caleb Nelson, Caleb Nelson, MD MPH, Boston Children's Hospital |
ClinicalTrials.gov Identifier: | NCT02235623 |
Other Study ID Numbers: |
P00008033 |
First Posted: | September 10, 2014 Key Record Dates |
Last Update Posted: | May 12, 2021 |
Last Verified: | April 2021 |
Laparoscopic Surgery Orchiopexy |
Cryptorchidism Testicular Diseases Urogenital Abnormalities |
Congenital Abnormalities Gonadal Disorders Endocrine System Diseases |